# US 2021/0277078 A1 · Fiber assembly and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277078 A1
- Document ID: US20210277078A1
- Status: Published application
- Kind: A1
- Application number: 16/962,828
- Filed: 2019-01-17
- Published: 2021-09-09
- Earliest claimed: 2018-01-17
- Assignees: National University Corporation Hokkaido University
- Applicants: National University Corporation Hokkaido University
- Inventors: Akira Kakugo
- Web page: https://patentgrep.com/patent/US20210277078A1

## CPC

- A61L 27/227: {Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24}
- C07K 14/4716: {Muscle proteins, e.g. myosin, actin}
- A61K 35/34: Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44)
- A61L 27/367: {Muscle tissue, e.g. sphincter}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- A61L 2300/258: Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
- A61L 2430/30: for muscle reconstruction
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A fiber assembly includes multiple fibers and nucleic acid fragments that crosslink the multiple fibers, and the fibers are microtubules or actin fibers.

## Claims

### Claim 1

A fiber assembly, comprising:
multiple fibers; and
nucleic acid fragments that crosslink the multiple fibers,
wherein the fibers are microtubules or actin fibers.

### Claim 2 (depends on 1)

The fiber assembly according to claim 1,
wherein the fibers include a first fiber and a second fiber,
wherein a first single-stranded nucleic acid fragment is bound to the first fiber,
wherein a second single-stranded nucleic acid fragment is bound to the second fiber,
wherein a third single-stranded nucleic acid fragment including a region complementary to the first single-stranded nucleic acid fragment and a region complementary to the second single-stranded nucleic acid fragment hybridizes with the first single-stranded nucleic acid fragment and the second single-stranded nucleic acid fragment, and thus the first fiber and the second fiber are crosslinked.

### Claim 3

A method of producing a fiber assembly,
wherein the fibers are microtubules or actin fibers,
the production method includes bringing a first fiber to which a first single-stranded nucleic acid fragment is bound, a second fiber to which a second single-stranded nucleic acid fragment is bound, and a third single-stranded nucleic acid fragment including a region complementary to the first single-stranded nucleic acid fragment and a region complementary to the second single-stranded nucleic acid fragment into contact with each other.

### Claim 4

A method of dissociating a fiber assembly into single fibers,
wherein the fibers are microtubules or actin fibers,
wherein the fiber assembly includes a first fiber to which a first single-stranded nucleic acid fragment is bound, a second fiber to which a second single-stranded nucleic acid fragment is bound, and a third single-stranded nucleic acid fragment including a region complementary to the first single-stranded nucleic acid fragment and a region complementary to the second single-stranded nucleic acid fragment, and
wherein the method includes bringing a fourth single-stranded nucleic acid fragment including a region complementary to the third single-stranded nucleic acid fragment into contact with the fiber assembly.

### Claim 5

A method of moving a fiber assembly,
wherein the fibers are microtubules or actin fibers,
wherein the fiber assembly includes a first fiber to which a first single-stranded nucleic acid fragment is bound, a second fiber to which a second single-stranded nucleic acid fragment is bound, and a third single-stranded nucleic acid fragment including a region complementary to the first single-stranded nucleic acid fragment and a region complementary to the second single-stranded nucleic acid fragment, and
wherein the method includes bringing the fiber assembly and adenosine triphosphate (ATP) into contact with each other on a substrate whose surface is covered with motor proteins.

### Claim 6 (depends on 5)

The method according to claim 5,
wherein the fibers are microtubules, and the motor proteins are kinesins or dyneins.

### Claim 7 (depends on 6)

The method according to claim 6,
wherein the microtubules are polymerized in the presence of guanosine-5′-triphosphate (GTP), and the fiber assembly moves in an arc.

### Claim 8 (depends on 6)

The method according to claim 6,
wherein at least some of the microtubules are polymerized in the presence of guanosine-5′-[α,β-methylene]triphosphate (GMPCPP), and the fiber assembly moves linearly.

### Claim 9 (depends on 5)

The method according to claim 5,
wherein the fibers are actin fibers, and the motor proteins are myosins.

### Claim 10

Artificial muscles, comprising:
multiple microtubules; and
kinesin or dynein multimers that crosslink the multiple microtubules.

### Claim 11 (depends on 10)

The artificial muscles according to claim 10,
wherein the kinesin or dynein multimers are a complex of biotinylated kinesin or biotinylated dynein, and avidin.

### Claim 12 (depends on 10)

The artificial muscles according to claim 10,
wherein the multiple microtubules include a first microtubule and a second microtubule,
wherein a first single-stranded nucleic acid fragment is bound to the first microtubule,
wherein a second single-stranded nucleic acid fragment is bound to the second microtubule,
wherein a third single-stranded nucleic acid fragment including a region complementary to the first single-stranded nucleic acid fragment and a region complementary to the second single-stranded nucleic acid fragment hybridizes with the first single-stranded nucleic acid fragment and the second single-stranded nucleic acid fragment, and thus the first microtubule and the second microtubule are crosslinked.

### Claim 13 (depends on 10)

A method of contracting the artificial muscles, comprising
bringing ATP into contact with the artificial muscles according to claim 10.

### Claim 14 (depends on 7)

The method according to claim 7,
wherein at least some of the microtubules are polymerized in the presence of guanosine-5′-[α,β-methylene]triphosphate (GMPCPP), and the fiber assembly moves linearly.

### Claim 15 (depends on 11)

The artificial muscles according to claim 11,
wherein the multiple microtubules include a first microtubule and a second microtubule,
wherein a first single-stranded nucleic acid fragment is bound to the first microtubule,
wherein a second single-stranded nucleic acid fragment is bound to the second microtubule,
wherein a third single-stranded nucleic acid fragment including a region complementary to the first single-stranded nucleic acid fragment and a region complementary to the second single-stranded nucleic acid fragment hybridizes with the first single-stranded nucleic acid fragment and the second single-stranded nucleic acid fragment, and thus the first microtubule and the second microtubule are crosslinked.

### Claim 16 (depends on 11)

A method of contracting the artificial muscles, comprising
bringing ATP into contact with the artificial muscles according to claim 11.

### Claim 17 (depends on 12)

A method of contracting the artificial muscles, comprising
bringing ATP into contact with the artificial muscles according to claim 12.
